SourceBio International PLC Director/PDMR Shareholding (3850A)

TIDMSBI

RNS Number : 3850A

SourceBio International PLC

02 February 2022

2 February 2022

SourceBio International plc

(" SourceBio", the "Company" or the "Group")

Director/PDMR Shareholding

SourceBio International plc ("the Company") has been notified that on 31 January 2022, Harwood Capital LLP transferred 4,737 ordinary shares of 0.15 pence each in the Company ("Ordinary Shares") to Limited Partners of Harwood Private Equity IV L.P. ("HPE4") in order to satisfy distributions, in the normal course of business.

Christopher Mills, Non-Executive Director of the Company is Chief Executive of Harwood Capital LLP.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                                 Harwood Capital LLP as investment 
                                            manager 
     ----------------------------------  ----------------------------------------- 
 2    Reason for the notification 
     ----------------------------------------------------------------------------- 
 a)   Position/status                     Christopher Mills is a non-executive 
                                           director of the issuer and Chief 
                                           Executive of the investment manager 
     ----------------------------------  ----------------------------------------- 
 b)   Initial notification                Initial Notification 
       /Amendment 
     ----------------------------------  ----------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ----------------------------------------------------------------------------- 
 a)   Name                                SourceBio International Plc 
     ----------------------------------  ----------------------------------------- 
 b)   LEI                                 213800KY4C9WU7WBW518 
     ----------------------------------  ----------------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ----------------------------------------------------------------------------- 
 a)   Description of the                  Ordinary shares of GBP0.0015 each 
       financial instrument, 
       type of instrument 
 
      Identification code                 GB00BKSB1674 
 
 b)   Nature of the transaction           Transfer of shares 
     ----------------------------------  ----------------------------------------- 
 c)   Price(s) and volume(s)                  Price(s)    Volume(s) 
                                               Nil         4,737 
                                                          ---------- 
                                           ------------------------------------- 
 d)   Aggregated information 
                                            N/A - single transaction 
       Volume 
       Price 
 e)   Date of the transaction             31 January 2022 
 f)   Place of the transaction                 Off market 
     ----------------------------------  ----------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFEDFVILIIF

(END) Dow Jones Newswires

February 02, 2022 02:00 ET (07:00 GMT)